Rank | Gene Set | Z-score |
---|---|---|
1 | detection of other organism (GO:0098543) | 4.64461852 |
2 | detection of bacterium (GO:0016045) | 4.39767305 |
3 | regulation of early endosome to late endosome transport (GO:2000641) | 4.35082033 |
4 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.27495913 |
5 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.26518163 |
6 | negative regulation of cell killing (GO:0031342) | 4.10150504 |
7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.10150504 |
8 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.06831720 |
9 | cellular extravasation (GO:0045123) | 4.05203645 |
10 | detection of molecule of bacterial origin (GO:0032490) | 4.03679971 |
11 | response to interleukin-15 (GO:0070672) | 4.00501998 |
12 | detection of external biotic stimulus (GO:0098581) | 3.99252019 |
13 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.98047542 |
14 | regulation of translational termination (GO:0006449) | 3.79063575 |
15 | neutrophil activation (GO:0042119) | 3.78885519 |
16 | germinal center formation (GO:0002467) | 3.73778174 |
17 | NIK/NF-kappaB signaling (GO:0038061) | 3.72901375 |
18 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.72714775 |
19 | myeloid cell activation involved in immune response (GO:0002275) | 3.66995394 |
20 | cellular response to interleukin-15 (GO:0071350) | 3.63763860 |
21 | granulocyte activation (GO:0036230) | 3.61493978 |
22 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.61104387 |
23 | detection of biotic stimulus (GO:0009595) | 3.59960633 |
24 | respiratory burst (GO:0045730) | 3.53236995 |
25 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.50637073 |
26 | macrophage activation (GO:0042116) | 3.50227075 |
27 | neutrophil mediated immunity (GO:0002446) | 3.45252854 |
28 | regulation of mast cell degranulation (GO:0043304) | 3.44535505 |
29 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.44352185 |
30 | natural killer cell mediated immunity (GO:0002228) | 3.44352185 |
31 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.43284813 |
32 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.40024140 |
33 | microglial cell activation (GO:0001774) | 3.38247802 |
34 | B cell receptor signaling pathway (GO:0050853) | 3.37614352 |
35 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.35171606 |
36 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.33724115 |
37 | negative regulation of T cell mediated immunity (GO:0002710) | 3.32032805 |
38 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.31579344 |
39 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.31579344 |
40 | modulation by symbiont of host immune response (GO:0052553) | 3.31579344 |
41 | positive regulation by symbiont of host defense response (GO:0052509) | 3.31579344 |
42 | modulation by symbiont of host defense response (GO:0052031) | 3.31579344 |
43 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.31579344 |
44 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.21348371 |
45 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.20682919 |
46 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.18552829 |
47 | tolerance induction (GO:0002507) | 3.18015861 |
48 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.14067875 |
49 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.14067875 |
50 | immunoglobulin mediated immune response (GO:0016064) | 3.13650946 |
51 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.11609029 |
52 | leukocyte degranulation (GO:0043299) | 3.11254360 |
53 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.10603273 |
54 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.09757615 |
55 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.09757615 |
56 | negative regulation of interleukin-6 production (GO:0032715) | 3.08990929 |
57 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.08548152 |
58 | positive regulation of interferon-alpha production (GO:0032727) | 3.07142907 |
59 | positive regulation of B cell differentiation (GO:0045579) | 3.06046317 |
60 | regulation of leukocyte degranulation (GO:0043300) | 3.05831926 |
61 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.04822193 |
62 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.04397365 |
63 | response to protozoan (GO:0001562) | 3.03084697 |
64 | negative thymic T cell selection (GO:0045060) | 3.01285024 |
65 | regulation of interferon-alpha production (GO:0032647) | 2.99904144 |
66 | regulation of mast cell activation (GO:0033003) | 2.97738046 |
67 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.97097562 |
68 | myeloid leukocyte mediated immunity (GO:0002444) | 2.95165906 |
69 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.94967317 |
70 | negative T cell selection (GO:0043383) | 2.93747598 |
71 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.88937347 |
72 | regulation of B cell differentiation (GO:0045577) | 2.88545782 |
73 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.88261524 |
74 | positive regulation of mast cell activation (GO:0033005) | 2.86646969 |
75 | barbed-end actin filament capping (GO:0051016) | 2.86553002 |
76 | T cell migration (GO:0072678) | 2.85271195 |
77 | response to muramyl dipeptide (GO:0032495) | 2.84427717 |
78 | regulation of gamma-delta T cell activation (GO:0046643) | 2.83555812 |
79 | regulation of integrin activation (GO:0033623) | 2.80673894 |
80 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.78444795 |
81 | myeloid leukocyte activation (GO:0002274) | 2.78388771 |
82 | regulation of tolerance induction (GO:0002643) | 2.74904962 |
83 | T-helper 1 type immune response (GO:0042088) | 2.74374160 |
84 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.74075248 |
85 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.70496445 |
86 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.66558687 |
87 | macrophage activation involved in immune response (GO:0002281) | 2.65955260 |
88 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.65535558 |
89 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.63579296 |
90 | leukocyte mediated cytotoxicity (GO:0001909) | 2.63318214 |
91 | response to peptidoglycan (GO:0032494) | 2.62221929 |
92 | modulation by symbiont of host cellular process (GO:0044068) | 2.61444487 |
93 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.60166786 |
94 | negative regulation of interleukin-12 production (GO:0032695) | 2.59506909 |
95 | cell adhesion mediated by integrin (GO:0033627) | 2.59437802 |
96 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.57791722 |
97 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.54434499 |
98 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.53349521 |
99 | B cell mediated immunity (GO:0019724) | 2.53173442 |
100 | positive thymic T cell selection (GO:0045059) | 2.46541777 |
101 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.44798102 |
102 | regulation of histone phosphorylation (GO:0033127) | 2.42987450 |
103 | NLS-bearing protein import into nucleus (GO:0006607) | 2.42175300 |
104 | protein localization to endosome (GO:0036010) | 2.40586467 |
105 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.37328339 |
106 | response to host (GO:0075136) | 2.37328339 |
107 | response to host defenses (GO:0052200) | 2.37328339 |
108 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.35152486 |
109 | membrane disassembly (GO:0030397) | 2.34808866 |
110 | nuclear envelope disassembly (GO:0051081) | 2.34808866 |
111 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.34614924 |
112 | response to host immune response (GO:0052572) | 2.34269935 |
113 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.34269935 |
114 | positive regulation of actin cytoskeleton reorganization (GO:2000251) | 2.33980750 |
115 | mitotic nuclear envelope disassembly (GO:0007077) | 2.33124876 |
116 | regulation of RIG-I signaling pathway (GO:0039535) | 2.32442100 |
117 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.31922088 |
118 | positive regulation of lamellipodium assembly (GO:0010592) | 2.31299346 |
119 | type I interferon signaling pathway (GO:0060337) | 2.31186934 |
120 | cellular response to type I interferon (GO:0071357) | 2.31186934 |
121 | response to type I interferon (GO:0034340) | 2.30604703 |
122 | actin nucleation (GO:0045010) | 2.30481321 |
123 | regulation of response to interferon-gamma (GO:0060330) | 2.30127452 |
124 | regulation of defense response to virus by virus (GO:0050690) | 2.27658031 |
125 | T cell apoptotic process (GO:0070231) | 2.27188935 |
126 | negative regulation of cell size (GO:0045792) | 2.26882168 |
127 | mitotic G1/S transition checkpoint (GO:0044819) | 2.25235414 |
128 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.23657479 |
129 | histone H2A monoubiquitination (GO:0035518) | 2.22921429 |
130 | positive regulation of lamellipodium organization (GO:1902745) | 2.22558546 |
131 | response to interferon-alpha (GO:0035455) | 2.21822432 |
132 | lymphocyte mediated immunity (GO:0002449) | 2.21183971 |
133 | pre-miRNA processing (GO:0031054) | 2.18312333 |
134 | cortical actin cytoskeleton organization (GO:0030866) | 2.17559457 |
135 | histone H2A ubiquitination (GO:0033522) | 2.17409080 |
136 | activation of JUN kinase activity (GO:0007257) | 2.17071606 |
137 | regulation of exit from mitosis (GO:0007096) | 2.17007059 |
138 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.16856661 |
139 | positive regulation of T cell apoptotic process (GO:0070234) | 2.15985201 |
140 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.15000017 |
141 | negative regulation of innate immune response (GO:0045824) | 2.08968590 |
142 | neutrophil activation involved in immune response (GO:0002283) | 2.07842604 |
143 | apoptotic cell clearance (GO:0043277) | 2.07586378 |
144 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.06926651 |
145 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.06889969 |
146 | nuclear envelope organization (GO:0006998) | 2.06661188 |
147 | sequestering of actin monomers (GO:0042989) | 2.06211960 |
148 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.05621919 |
149 | apoptotic process involved in morphogenesis (GO:0060561) | 2.05555545 |
150 | leukocyte aggregation (GO:0070486) | 2.05330915 |
151 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.04403351 |
152 | defense response to protozoan (GO:0042832) | 2.03118897 |
153 | response to nerve growth factor (GO:1990089) | 2.03025965 |
154 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.03025965 |
155 | regulation of mitotic spindle organization (GO:0060236) | 2.02938924 |
156 | leukocyte cell-cell adhesion (GO:0007159) | 2.02791749 |
157 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.02261488 |
158 | thymic T cell selection (GO:0045061) | 2.01806397 |
159 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 2.01748715 |
160 | positive regulation of histone acetylation (GO:0035066) | 2.01172693 |
161 | Fc-gamma receptor signaling pathway (GO:0038094) | 2.01030426 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.28883846 |
2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.26322693 |
3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.18406062 |
4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.11270549 |
5 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.77853776 |
6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.74188268 |
7 | MYC_22102868_ChIP-Seq_BL_Human | 2.67757491 |
8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.52157415 |
9 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.51959121 |
10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.27843084 |
11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.26235699 |
12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.15321796 |
13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.13179986 |
14 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.13019809 |
15 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.12922632 |
16 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.04410126 |
17 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.99507059 |
18 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.98503175 |
19 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.89820584 |
20 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.89060650 |
21 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.88449206 |
22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.87642012 |
23 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.86487301 |
24 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.84266248 |
25 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.83508968 |
26 | SPI1_23127762_ChIP-Seq_K562_Human | 1.75472349 |
27 | MAF_26560356_Chip-Seq_TH1_Human | 1.75240789 |
28 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.74361969 |
29 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.70023762 |
30 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.69348424 |
31 | ATF3_27146783_Chip-Seq_COLON_Human | 1.65388580 |
32 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.64146423 |
33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.64054827 |
34 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.63744128 |
35 | UTX_26944678_Chip-Seq_JUKART_Human | 1.63325604 |
36 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.62321429 |
37 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.61009800 |
38 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.60562783 |
39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.59008381 |
40 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.58513065 |
41 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.56583171 |
42 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.56268277 |
43 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.53582300 |
44 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.51725765 |
45 | * MYB_26560356_Chip-Seq_TH2_Human | 1.49161320 |
46 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.46886609 |
47 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.45982389 |
48 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.45872125 |
49 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.45833420 |
50 | MAF_26560356_Chip-Seq_TH2_Human | 1.39733855 |
51 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39336118 |
52 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39036941 |
53 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.37540994 |
54 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.36916919 |
55 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.35754944 |
56 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35567037 |
57 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.35425625 |
58 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.34437294 |
59 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.34029994 |
60 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.33808010 |
61 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.33586056 |
62 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31391234 |
63 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.31344626 |
64 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.31183054 |
65 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.30915562 |
66 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30651173 |
67 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.29955143 |
68 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.28693867 |
69 | * MYB_26560356_Chip-Seq_TH1_Human | 1.27334149 |
70 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.27328307 |
71 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.27285253 |
72 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26528256 |
73 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.26266321 |
74 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.26166920 |
75 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.26115788 |
76 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24999396 |
77 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23422192 |
78 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.22594807 |
79 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.21726508 |
80 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.21392581 |
81 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21343552 |
82 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.20949184 |
83 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.19271101 |
84 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.18648043 |
85 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.18161173 |
86 | KDM2B_26808549_Chip-Seq_K562_Human | 1.18107678 |
87 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.17734388 |
88 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.16631541 |
89 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.15544500 |
90 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.15086526 |
91 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.14587740 |
92 | P68_20966046_ChIP-Seq_HELA_Human | 1.14507949 |
93 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.14499610 |
94 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.14035834 |
95 | GATA1_19941826_ChIP-Seq_K562_Human | 1.13425027 |
96 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12833939 |
97 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12762584 |
98 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.12036216 |
99 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.11809053 |
100 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11410786 |
101 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.11262703 |
102 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09728470 |
103 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.09454635 |
104 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.08897383 |
105 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.08705909 |
106 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.08369950 |
107 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08353539 |
108 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07972119 |
109 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07950366 |
110 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07453740 |
111 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06508478 |
112 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.06493714 |
113 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.05046260 |
114 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04157766 |
115 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.04125960 |
116 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03933493 |
117 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02415332 |
118 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01866589 |
119 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.01806007 |
120 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.01682109 |
121 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.01169383 |
122 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.00956748 |
123 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.99961506 |
124 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99836090 |
125 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.99792921 |
126 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.98838865 |
127 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.98345628 |
128 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98144740 |
129 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.97545176 |
130 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97513109 |
131 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.97409845 |
132 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.97066163 |
133 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96983654 |
134 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.96343484 |
135 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.93769751 |
136 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.93174793 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0000569_abnormal_digit_pigmentation | 3.14870926 |
2 | MP0003303_peritoneal_inflammation | 2.75939264 |
3 | MP0009278_abnormal_bone_marrow | 2.55967987 |
4 | MP0003172_abnormal_lysosome_physiology | 2.46139917 |
5 | MP0004510_myositis | 2.45419096 |
6 | MP0005058_abnormal_lysosome_morphology | 2.37648233 |
7 | MP0004858_abnormal_nervous_system | 2.34357105 |
8 | MP0003705_abnormal_hypodermis_morpholog | 2.26897277 |
9 | MP0008260_abnormal_autophagy | 2.23376310 |
10 | MP0000685_abnormal_immune_system | 2.19997552 |
11 | MP0003436_decreased_susceptibility_to | 2.15432869 |
12 | MP0004947_skin_inflammation | 2.13371413 |
13 | MP0010352_gastrointestinal_tract_polyps | 2.11149835 |
14 | MP0001545_abnormal_hematopoietic_system | 2.10111764 |
15 | MP0005397_hematopoietic_system_phenotyp | 2.10111764 |
16 | MP0001958_emphysema | 2.04929533 |
17 | MP0010234_abnormal_vibrissa_follicle | 2.02612597 |
18 | MP0003693_abnormal_embryo_hatching | 1.98469591 |
19 | MP0010307_abnormal_tumor_latency | 1.97083459 |
20 | MP0003566_abnormal_cell_adhesion | 1.94149040 |
21 | MP0004859_abnormal_synaptic_plasticity | 1.92785391 |
22 | MP0005451_abnormal_body_composition | 1.82447186 |
23 | MP0005076_abnormal_cell_differentiation | 1.76968820 |
24 | MP0001835_abnormal_antigen_presentation | 1.75029984 |
25 | MP0009785_altered_susceptibility_to | 1.74361880 |
26 | MP0005387_immune_system_phenotype | 1.70890678 |
27 | MP0001790_abnormal_immune_system | 1.70890678 |
28 | MP0009764_decreased_sensitivity_to | 1.70150298 |
29 | MP0003111_abnormal_nucleus_morphology | 1.68198012 |
30 | MP0003300_gastrointestinal_ulcer | 1.67576151 |
31 | MP0005464_abnormal_platelet_physiology | 1.66348942 |
32 | MP0003091_abnormal_cell_migration | 1.66293420 |
33 | MP0003448_altered_tumor_morphology | 1.65761426 |
34 | MP0005000_abnormal_immune_tolerance | 1.64847153 |
35 | MP0000858_altered_metastatic_potential | 1.64616239 |
36 | MP0003329_amyloid_beta_deposits | 1.62709168 |
37 | MP0005023_abnormal_wound_healing | 1.60690568 |
38 | MP0005025_abnormal_response_to | 1.60663823 |
39 | MP0002132_abnormal_respiratory_system | 1.60561190 |
40 | MP0003828_pulmonary_edema | 1.57560850 |
41 | MP0000604_amyloidosis | 1.57297834 |
42 | MP0002452_abnormal_antigen_presenting | 1.54719560 |
43 | MP0002723_abnormal_immune_serum | 1.54482437 |
44 | MP0002419_abnormal_innate_immunity | 1.52059257 |
45 | MP0001819_abnormal_immune_cell | 1.47152902 |
46 | MP0001800_abnormal_humoral_immune | 1.46571004 |
47 | MP0002398_abnormal_bone_marrow | 1.46161363 |
48 | MP0002420_abnormal_adaptive_immunity | 1.45296558 |
49 | MP0002405_respiratory_system_inflammati | 1.44140256 |
50 | MP0003453_abnormal_keratinocyte_physiol | 1.41389203 |
51 | MP0003077_abnormal_cell_cycle | 1.40168266 |
52 | MP0004808_abnormal_hematopoietic_stem | 1.35196322 |
53 | MP0008469_abnormal_protein_level | 1.35000629 |
54 | MP0009840_abnormal_foam_cell | 1.32510144 |
55 | MP0004782_abnormal_surfactant_physiolog | 1.31426581 |
56 | MP0002998_abnormal_bone_remodeling | 1.30611077 |
57 | MP0005671_abnormal_response_to | 1.30310479 |
58 | MP0001849_ear_inflammation | 1.29872618 |
59 | MP0001730_embryonic_growth_arrest | 1.29458513 |
60 | MP0004957_abnormal_blastocyst_morpholog | 1.28327378 |
61 | MP0003646_muscle_fatigue | 1.28126830 |
62 | MP0003866_abnormal_defecation | 1.26953330 |
63 | MP0008004_abnormal_stomach_pH | 1.26145053 |
64 | MP0001853_heart_inflammation | 1.25042635 |
65 | MP0003763_abnormal_thymus_physiology | 1.23515934 |
66 | MP0005621_abnormal_cell_physiology | 1.21248806 |
67 | MP0000716_abnormal_immune_system | 1.20149593 |
68 | MP0009333_abnormal_splenocyte_physiolog | 1.18470116 |
69 | MP0000689_abnormal_spleen_morphology | 1.18007213 |
70 | MP0002722_abnormal_immune_system | 1.15265320 |
71 | MP0002396_abnormal_hematopoietic_system | 1.14966650 |
72 | MP0004381_abnormal_hair_follicle | 1.12269884 |
73 | MP0001533_abnormal_skeleton_physiology | 1.12263318 |
74 | MP0010155_abnormal_intestine_physiology | 1.11344202 |
75 | MP0000371_diluted_coat_color | 1.07681712 |
76 | MP0002429_abnormal_blood_cell | 1.07094428 |
77 | MP0000350_abnormal_cell_proliferation | 1.07026836 |
78 | MP0001851_eye_inflammation | 1.06786294 |
79 | MP0000465_gastrointestinal_hemorrhage | 1.06383692 |
80 | MP0000733_abnormal_muscle_development | 1.05675283 |
81 | MP0003183_abnormal_peptide_metabolism | 1.04961827 |
82 | MP0000343_altered_response_to | 1.04940055 |
83 | MP0002148_abnormal_hypersensitivity_rea | 1.03720852 |
84 | MP0000490_abnormal_crypts_of | 1.01829466 |
85 | MP0006082_CNS_inflammation | 1.01762360 |
86 | MP0002019_abnormal_tumor_incidence | 1.01625363 |
87 | MP0010094_abnormal_chromosome_stability | 1.00926380 |
88 | MP0003724_increased_susceptibility_to | 1.00412375 |
89 | MP0003656_abnormal_erythrocyte_physiolo | 0.99260341 |
90 | MP0000703_abnormal_thymus_morphology | 0.99017281 |
91 | MP0001845_abnormal_inflammatory_respons | 0.97923398 |
92 | MP0005390_skeleton_phenotype | 0.97561719 |
93 | MP0005083_abnormal_biliary_tract | 0.96190845 |
94 | MP0002006_tumorigenesis | 0.95489044 |
95 | MP0005257_abnormal_intraocular_pressure | 0.94298005 |
96 | MP0002653_abnormal_ependyma_morphology | 0.92923226 |
97 | MP0001663_abnormal_digestive_system | 0.91460370 |
98 | MP0002933_joint_inflammation | 0.90417242 |
99 | MP0005384_cellular_phenotype | 0.88388008 |
100 | MP0002277_abnormal_respiratory_mucosa | 0.87702620 |
101 | MP0003283_abnormal_digestive_organ | 0.85581184 |
102 | MP0002166_altered_tumor_susceptibility | 0.85392680 |
103 | MP0003690_abnormal_glial_cell | 0.83790440 |
104 | MP0004883_abnormal_blood_vessel | 0.82720773 |
105 | MP0000015_abnormal_ear_pigmentation | 0.81907645 |
106 | MP0005164_abnormal_response_to | 0.81311542 |
107 | MP0005166_decreased_susceptibility_to | 0.81028260 |
108 | MP0009763_increased_sensitivity_to | 0.80204382 |
109 | MP0005310_abnormal_salivary_gland | 0.80089796 |
110 | MP0003075_altered_response_to | 0.78681720 |
111 | MP0008961_abnormal_basal_metabolism | 0.77501749 |
112 | MP0004130_abnormal_muscle_cell | 0.77146072 |
113 | MP0002332_abnormal_exercise_endurance | 0.76449941 |
114 | MP0003045_fibrosis | 0.76044099 |
115 | MP0004185_abnormal_adipocyte_glucose | 0.75045907 |
116 | MP0005174_abnormal_tail_pigmentation | 0.74548171 |
117 | MP0005275_abnormal_skin_tensile | 0.73420369 |
118 | MP0001873_stomach_inflammation | 0.73374530 |
119 | MP0002080_prenatal_lethality | 0.73134555 |
120 | MP0003718_maternal_effect | 0.73079845 |
121 | MP0009765_abnormal_xenobiotic_induced | 0.72849820 |
122 | MP0002138_abnormal_hepatobiliary_system | 0.71941698 |
123 | MP0003191_abnormal_cellular_cholesterol | 0.70968025 |
124 | MP0000313_abnormal_cell_death | 0.70810373 |
125 | MP0002009_preneoplasia | 0.68772059 |
126 | MP0000358_abnormal_cell_content/ | 0.67232018 |
127 | MP0005167_abnormal_blood-brain_barrier | 0.67078387 |
128 | MP0008874_decreased_physiological_sensi | 0.63806278 |
129 | MP0003221_abnormal_cardiomyocyte_apopto | 0.63461525 |
130 | MP0000249_abnormal_blood_vessel | 0.62315539 |
131 | MP0003795_abnormal_bone_structure | 0.59273600 |
132 | MP0002254_reproductive_system_inflammat | 0.54387066 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Interstitial pulmonary disease (HP:0006530) | 4.46300867 |
2 | Gastrointestinal infarctions (HP:0005244) | 4.03963592 |
3 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.92257597 |
4 | Keratoconjunctivitis sicca (HP:0001097) | 3.90172998 |
5 | Obstructive lung disease (HP:0006536) | 3.80200901 |
6 | Chronic obstructive pulmonary disease (HP:0006510) | 3.80200901 |
7 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.79941116 |
8 | Meningitis (HP:0001287) | 3.67952897 |
9 | Keratoconjunctivitis (HP:0001096) | 3.63712512 |
10 | Recurrent cutaneous fungal infections (HP:0011370) | 3.55495761 |
11 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.55495761 |
12 | Eczematoid dermatitis (HP:0000976) | 3.54227928 |
13 | Recurrent abscess formation (HP:0002722) | 3.42046318 |
14 | Encephalitis (HP:0002383) | 3.36789282 |
15 | Cerebral aneurysm (HP:0004944) | 3.26575747 |
16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.20160344 |
17 | Prolonged bleeding time (HP:0003010) | 3.06909355 |
18 | Spontaneous hematomas (HP:0007420) | 3.04099985 |
19 | Urticaria (HP:0001025) | 3.01262471 |
20 | Chest pain (HP:0100749) | 3.00952486 |
21 | Recurrent bacterial skin infections (HP:0005406) | 3.00442619 |
22 | Hemoptysis (HP:0002105) | 2.99075771 |
23 | T lymphocytopenia (HP:0005403) | 2.90175616 |
24 | Dysostosis multiplex (HP:0000943) | 2.89677468 |
25 | Increased IgM level (HP:0003496) | 2.88280097 |
26 | Hypochromic anemia (HP:0001931) | 2.86590953 |
27 | Increased cerebral lipofuscin (HP:0011813) | 2.86183677 |
28 | Arterial thrombosis (HP:0004420) | 2.81323190 |
29 | Abnormality of T cell number (HP:0011839) | 2.80017102 |
30 | Difficulty climbing stairs (HP:0003551) | 2.73251254 |
31 | Annular pancreas (HP:0001734) | 2.72729692 |
32 | Myositis (HP:0100614) | 2.72112208 |
33 | Long toe (HP:0010511) | 2.72057588 |
34 | Episodic fever (HP:0001954) | 2.70108375 |
35 | Distal upper limb amyotrophy (HP:0007149) | 2.68967422 |
36 | Upper limb amyotrophy (HP:0009129) | 2.68967422 |
37 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.68622601 |
38 | Abnormality of macrophages (HP:0004311) | 2.68117841 |
39 | Hand muscle atrophy (HP:0009130) | 2.63331793 |
40 | Epistaxis (HP:0000421) | 2.58016372 |
41 | Panhypogammaglobulinemia (HP:0003139) | 2.57256836 |
42 | Anorexia (HP:0002039) | 2.56317245 |
43 | Hypochromic microcytic anemia (HP:0004840) | 2.54995049 |
44 | Inflammation of the large intestine (HP:0002037) | 2.54780970 |
45 | Nasal polyposis (HP:0100582) | 2.54764477 |
46 | Abnormality of the nasal mucosa (HP:0000433) | 2.54674905 |
47 | Mediastinal lymphadenopathy (HP:0100721) | 2.53478835 |
48 | Granulocytopenia (HP:0001913) | 2.52993693 |
49 | Amyloidosis (HP:0011034) | 2.50869188 |
50 | Gastrointestinal inflammation (HP:0004386) | 2.50672869 |
51 | Colitis (HP:0002583) | 2.47450802 |
52 | Frequent falls (HP:0002359) | 2.45720989 |
53 | Abnormality of the pleura (HP:0002103) | 2.43868322 |
54 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.42467063 |
55 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.42467063 |
56 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.42467063 |
57 | Abnormality of T cells (HP:0002843) | 2.41720000 |
58 | Supranuclear gaze palsy (HP:0000605) | 2.41653139 |
59 | Abnormality of the fingertips (HP:0001211) | 2.39672751 |
60 | Pustule (HP:0200039) | 2.37580415 |
61 | Stomatitis (HP:0010280) | 2.35655137 |
62 | Mucopolysacchariduria (HP:0008155) | 2.34391334 |
63 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.34391334 |
64 | Increased density of long bones (HP:0006392) | 2.33224136 |
65 | Increased serum ferritin (HP:0003281) | 2.33054644 |
66 | Pulmonary embolism (HP:0002204) | 2.32367085 |
67 | Radial bowing (HP:0002986) | 2.32262613 |
68 | Peritonitis (HP:0002586) | 2.32045170 |
69 | Agammaglobulinemia (HP:0004432) | 2.26174172 |
70 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.24666030 |
71 | Orchitis (HP:0100796) | 2.24540060 |
72 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.23788129 |
73 | Gangrene (HP:0100758) | 2.23659639 |
74 | Autoimmune thrombocytopenia (HP:0001973) | 2.23364411 |
75 | Abnormality of the peritoneum (HP:0002585) | 2.22408143 |
76 | Abnormality of the endocardium (HP:0004306) | 2.21815948 |
77 | Petechiae (HP:0000967) | 2.20805610 |
78 | Global brain atrophy (HP:0002283) | 2.20054034 |
79 | Dilatation of the ascending aorta (HP:0005111) | 2.19797209 |
80 | Achilles tendon contracture (HP:0001771) | 2.19345060 |
81 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.18067789 |
82 | Increased IgE level (HP:0003212) | 2.17598593 |
83 | Lymphopenia (HP:0001888) | 2.16573924 |
84 | Hematochezia (HP:0002573) | 2.16504694 |
85 | Keratitis (HP:0000491) | 2.16358224 |
86 | Genu recurvatum (HP:0002816) | 2.15652540 |
87 | Recurrent fungal infections (HP:0002841) | 2.15309119 |
88 | Short nail (HP:0001799) | 2.14432739 |
89 | Gingival bleeding (HP:0000225) | 2.13409718 |
90 | Sepsis (HP:0100806) | 2.10422539 |
91 | Diminished motivation (HP:0000745) | 2.10009929 |
92 | Hepatosplenomegaly (HP:0001433) | 2.09809572 |
93 | Chronic otitis media (HP:0000389) | 2.09788373 |
94 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.08492002 |
95 | Osteolytic defects of the hand bones (HP:0009699) | 2.08492002 |
96 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.08130274 |
97 | Abnormality of iron homeostasis (HP:0011031) | 2.08012851 |
98 | Abnormality of glycolipid metabolism (HP:0010969) | 2.05784357 |
99 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.05784357 |
100 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.05784357 |
101 | Pointed chin (HP:0000307) | 2.04936409 |
102 | Abnormality of the pericardium (HP:0001697) | 2.03490937 |
103 | Acne (HP:0001061) | 2.02974143 |
104 | Glomerulopathy (HP:0100820) | 2.02192014 |
105 | Apathy (HP:0000741) | 2.02094748 |
106 | Hyperacusis (HP:0010780) | 2.01277668 |
107 | Loss of speech (HP:0002371) | 2.00758321 |
108 | Abnormality of T cell physiology (HP:0011840) | 1.99960890 |
109 | Vertigo (HP:0002321) | 1.98929726 |
110 | Gingivitis (HP:0000230) | 1.98883597 |
111 | Eosinophilia (HP:0001880) | 1.98875118 |
112 | Gastrointestinal stroma tumor (HP:0100723) | 1.98763606 |
113 | Slow saccadic eye movements (HP:0000514) | 1.98188924 |
114 | Thoracic kyphosis (HP:0002942) | 1.94810233 |
115 | Cellulitis (HP:0100658) | 1.94511360 |
116 | Rapidly progressive (HP:0003678) | 1.92955223 |
117 | Vertebral compression fractures (HP:0002953) | 1.90715594 |
118 | Personality changes (HP:0000751) | 1.89549723 |
119 | Visual hallucinations (HP:0002367) | 1.87787732 |
120 | Ulnar bowing (HP:0003031) | 1.86580272 |
121 | Retrobulbar optic neuritis (HP:0100654) | 1.86427917 |
122 | Optic neuritis (HP:0100653) | 1.86427917 |
123 | Abnormality of eosinophils (HP:0001879) | 1.84981235 |
124 | Joint swelling (HP:0001386) | 1.84747922 |
125 | Restrictive lung disease (HP:0002091) | 1.83318086 |
126 | Emphysema (HP:0002097) | 1.82757776 |
127 | Protrusio acetabuli (HP:0003179) | 1.80676483 |
128 | Periodontitis (HP:0000704) | 1.77738091 |
129 | Premature ovarian failure (HP:0008209) | 1.76213380 |
130 | Deep palmar crease (HP:0006191) | 1.73405433 |
131 | Spinal muscular atrophy (HP:0007269) | 1.72715466 |
132 | Bowed forearm bones (HP:0003956) | 1.72391191 |
133 | Bowing of the arm (HP:0006488) | 1.72391191 |
134 | Ankle contracture (HP:0006466) | 1.71869863 |
135 | Ocular albinism (HP:0001107) | 1.68122885 |
136 | Shallow orbits (HP:0000586) | 1.67955189 |
137 | Pelvic girdle muscle weakness (HP:0003749) | 1.67773090 |
138 | Wrist flexion contracture (HP:0001239) | 1.67609442 |
139 | Abnormality of the Achilles tendon (HP:0005109) | 1.67242221 |
140 | Tetraparesis (HP:0002273) | 1.65596009 |
141 | Cortical dysplasia (HP:0002539) | 1.65495055 |
142 | Leukocytosis (HP:0001974) | 1.64595239 |
143 | Broad distal phalanx of finger (HP:0009836) | 1.64044347 |
144 | Cervical subluxation (HP:0003308) | 1.63140898 |
145 | Recurrent viral infections (HP:0004429) | 1.62908322 |
146 | Milia (HP:0001056) | 1.62317649 |
147 | Abnormality of the motor neurons (HP:0002450) | 1.61826170 |
148 | Abnormal neuron morphology (HP:0012757) | 1.61826170 |
149 | Distal lower limb amyotrophy (HP:0008944) | 1.61325747 |
150 | Selective tooth agenesis (HP:0001592) | 1.60752628 |
151 | Osteomyelitis (HP:0002754) | 1.57906748 |
152 | Recurrent skin infections (HP:0001581) | 1.56930730 |
153 | Pulmonary infiltrates (HP:0002113) | 1.56891650 |
154 | Degeneration of anterior horn cells (HP:0002398) | 1.56703981 |
155 | Abnormality of the anterior horn cell (HP:0006802) | 1.56703981 |
156 | Vasculitis (HP:0002633) | 1.56496260 |
157 | Basal cell carcinoma (HP:0002671) | 1.55342022 |
158 | Myokymia (HP:0002411) | 1.54489363 |
159 | Hypergammaglobulinemia (HP:0010702) | 1.54246229 |
160 | Ulnar deviation of the wrist (HP:0003049) | 1.52870626 |
161 | Premature loss of primary teeth (HP:0006323) | 1.51905188 |
162 | Iris hypopigmentation (HP:0007730) | 1.51802318 |
163 | Albinism (HP:0001022) | 1.51496206 |
164 | Bowel diverticulosis (HP:0005222) | 1.49561203 |
165 | Neuronal loss in central nervous system (HP:0002529) | 1.49368988 |
166 | Aortic aneurysm (HP:0004942) | 1.49263277 |
167 | Lower limb amyotrophy (HP:0007210) | 1.49235706 |
168 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.48992329 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K9 | 4.01106332 |
2 | KSR2 | 3.31625240 |
3 | TRIB3 | 3.02133405 |
4 | IRAK4 | 2.99374779 |
5 | EEF2K | 2.62355076 |
6 | MAP3K13 | 2.47484084 |
7 | MAP4K1 | 2.31977696 |
8 | RIPK4 | 2.27791784 |
9 | PKN2 | 2.27417452 |
10 | PRPF4B | 2.17650697 |
11 | GRK6 | 2.15051117 |
12 | CSK | 2.12843113 |
13 | TAOK1 | 2.01072334 |
14 | ZAP70 | 1.96887236 |
15 | SCYL2 | 1.91882094 |
16 | MAPKAPK3 | 1.83757019 |
17 | BLK | 1.83533389 |
18 | ERN1 | 1.81097718 |
19 | LATS2 | 1.79614484 |
20 | TESK2 | 1.79262825 |
21 | TYK2 | 1.77522001 |
22 | BTK | 1.74528304 |
23 | NEK2 | 1.74393603 |
24 | TNK2 | 1.73491569 |
25 | MAP3K11 | 1.64141806 |
26 | JAK3 | 1.53992855 |
27 | TBK1 | 1.47009164 |
28 | TESK1 | 1.46579231 |
29 | TTN | 1.43654485 |
30 | ARAF | 1.34267662 |
31 | IRAK3 | 1.33594724 |
32 | LRRK2 | 1.30338363 |
33 | SMG1 | 1.30264562 |
34 | MOS | 1.28875909 |
35 | MAP3K10 | 1.28088259 |
36 | STK10 | 1.25119521 |
37 | PRKD3 | 1.23097011 |
38 | FGFR4 | 1.22254546 |
39 | ALK | 1.20488215 |
40 | JAK1 | 1.19930921 |
41 | LYN | 1.18225333 |
42 | RET | 1.17750472 |
43 | PAK6 | 1.17096005 |
44 | KSR1 | 1.16860097 |
45 | KIT | 1.15248499 |
46 | MARK2 | 1.15188308 |
47 | IKBKB | 1.14869682 |
48 | PAK4 | 1.10555022 |
49 | IRAK2 | 1.10294597 |
50 | SIK2 | 1.09957808 |
51 | IKBKE | 1.09764306 |
52 | MAP3K12 | 1.09089336 |
53 | RAF1 | 1.08139849 |
54 | EPHB1 | 1.06989312 |
55 | MAP3K1 | 1.06350088 |
56 | MAP3K8 | 1.04049365 |
57 | CDC42BPA | 1.03021978 |
58 | IRAK1 | 1.02907540 |
59 | MAP3K7 | 1.02884171 |
60 | PRKD2 | 1.02205124 |
61 | EPHA2 | 1.01821976 |
62 | BUB1 | 1.00652440 |
63 | LIMK1 | 0.99552905 |
64 | CDK12 | 0.99283633 |
65 | CSF1R | 0.98721974 |
66 | HCK | 0.98612513 |
67 | MAP2K3 | 0.97065925 |
68 | MAP3K2 | 0.95583927 |
69 | MAP3K6 | 0.95477471 |
70 | RPS6KA4 | 0.94820271 |
71 | TYRO3 | 0.92560017 |
72 | ITK | 0.89263499 |
73 | RIPK1 | 0.87384714 |
74 | FES | 0.87122937 |
75 | TAOK2 | 0.86613172 |
76 | MAP3K5 | 0.85457080 |
77 | NTRK1 | 0.84386954 |
78 | DYRK1B | 0.83415798 |
79 | DAPK2 | 0.81695337 |
80 | RPS6KC1 | 0.78700125 |
81 | RPS6KL1 | 0.78700125 |
82 | MAP3K14 | 0.75660661 |
83 | NEK1 | 0.74765935 |
84 | HIPK2 | 0.74435800 |
85 | TXK | 0.74328231 |
86 | BMX | 0.74133802 |
87 | RPS6KA6 | 0.74056940 |
88 | ICK | 0.73466807 |
89 | DAPK1 | 0.71580014 |
90 | MAP2K6 | 0.70878794 |
91 | SIK3 | 0.69909645 |
92 | MAPK12 | 0.69318276 |
93 | MAP2K4 | 0.69086758 |
94 | CAMKK1 | 0.68727784 |
95 | SYK | 0.67928574 |
96 | MAP3K3 | 0.67318174 |
97 | MAPK7 | 0.66098087 |
98 | STK38 | 0.64673198 |
99 | DAPK3 | 0.63892362 |
100 | RPS6KB2 | 0.61135057 |
101 | PDGFRA | 0.61098672 |
102 | TEC | 0.60525188 |
103 | PTK2 | 0.60198120 |
104 | PTK6 | 0.59776627 |
105 | EPHA3 | 0.59414856 |
106 | MAP2K2 | 0.59269279 |
107 | CDK19 | 0.56682016 |
108 | JAK2 | 0.56373693 |
109 | YES1 | 0.55764653 |
110 | STK11 | 0.55457608 |
111 | FGR | 0.54347195 |
112 | RPS6KA2 | 0.52833143 |
113 | PTK2B | 0.51956042 |
114 | GRK7 | 0.50936392 |
115 | MAPK11 | 0.50693509 |
116 | MTOR | 0.50151412 |
117 | FER | 0.49920894 |
118 | FGFR3 | 0.49622461 |
119 | PRKCQ | 0.49544121 |
120 | BMPR2 | 0.49207755 |
121 | PDGFRB | 0.48803159 |
122 | FYN | 0.48326582 |
123 | MATK | 0.48259253 |
124 | CDK4 | 0.48038389 |
125 | MINK1 | 0.47650252 |
126 | CDK6 | 0.47046546 |
127 | ERBB4 | 0.46610908 |
128 | KDR | 0.46301647 |
129 | PDK1 | 0.45037917 |
130 | PAK1 | 0.44531817 |
131 | PRKCH | 0.43649422 |
132 | MAP2K1 | 0.43350217 |
133 | SIK1 | 0.43233598 |
134 | LCK | 0.43051210 |
135 | PIM2 | 0.41964503 |
136 | PIM1 | 0.41201691 |
137 | TAOK3 | 0.40022095 |
138 | PDPK1 | 0.39394604 |
139 | MARK3 | 0.37918221 |
140 | EGFR | 0.36964306 |
141 | CAMK4 | 0.36736386 |
142 | WEE1 | 0.36734173 |
143 | CHUK | 0.34708828 |
144 | AURKA | 0.33954915 |
145 | TTK | 0.33638812 |
146 | BRAF | 0.32023600 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.22350375 |
2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.01048742 |
3 | Allograft rejection_Homo sapiens_hsa05330 | 1.98886079 |
4 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.96181495 |
5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.78475229 |
6 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.77673230 |
7 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.73897029 |
8 | Leishmaniasis_Homo sapiens_hsa05140 | 1.64553422 |
9 | Shigellosis_Homo sapiens_hsa05131 | 1.62271732 |
10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.55135144 |
11 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.50303394 |
12 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.45682934 |
13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.44986705 |
14 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.43613560 |
15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.41709350 |
16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.39979773 |
17 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.39943263 |
18 | Apoptosis_Homo sapiens_hsa04210 | 1.33800243 |
19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.30861525 |
20 | Tuberculosis_Homo sapiens_hsa05152 | 1.30408004 |
21 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.29413211 |
22 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.27955111 |
23 | Influenza A_Homo sapiens_hsa05164 | 1.25069291 |
24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.24404330 |
25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.22764606 |
26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.22406685 |
27 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.21935393 |
28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.20890296 |
29 | Lysosome_Homo sapiens_hsa04142 | 1.19966136 |
30 | Salmonella infection_Homo sapiens_hsa05132 | 1.16890817 |
31 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.16455143 |
32 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.15340408 |
33 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.15231169 |
34 | Glioma_Homo sapiens_hsa05214 | 1.14894810 |
35 | Hepatitis B_Homo sapiens_hsa05161 | 1.13045570 |
36 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.12584742 |
37 | Measles_Homo sapiens_hsa05162 | 1.10617012 |
38 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.10114135 |
39 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.10013557 |
40 | Asthma_Homo sapiens_hsa05310 | 1.08130822 |
41 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.07334619 |
42 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.07296495 |
43 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.07138674 |
44 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.05969668 |
45 | Pertussis_Homo sapiens_hsa05133 | 1.05602602 |
46 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.04935218 |
47 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.04494392 |
48 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.03877977 |
49 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.03418742 |
50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.02121171 |
51 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.00208023 |
52 | Bladder cancer_Homo sapiens_hsa05219 | 0.99170218 |
53 | Legionellosis_Homo sapiens_hsa05134 | 0.98625699 |
54 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.98572749 |
55 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.98568066 |
56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.97993863 |
57 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.97940627 |
58 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.97683541 |
59 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.97362735 |
60 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.94914180 |
61 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.93861304 |
62 | Endocytosis_Homo sapiens_hsa04144 | 0.93476089 |
63 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.92230075 |
64 | Colorectal cancer_Homo sapiens_hsa05210 | 0.92097908 |
65 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.91608313 |
66 | Phagosome_Homo sapiens_hsa04145 | 0.91032741 |
67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90799531 |
68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.90070709 |
69 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.88772411 |
70 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.87727547 |
71 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.87274424 |
72 | Malaria_Homo sapiens_hsa05144 | 0.87123376 |
73 | Viral myocarditis_Homo sapiens_hsa05416 | 0.86304359 |
74 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.86215637 |
75 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.85890867 |
76 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.85160017 |
77 | RNA transport_Homo sapiens_hsa03013 | 0.83467194 |
78 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.82369119 |
79 | Platelet activation_Homo sapiens_hsa04611 | 0.81837473 |
80 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.81197706 |
81 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.80012184 |
82 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.79497645 |
83 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.79231433 |
84 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.78639189 |
85 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.78167448 |
86 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77590486 |
87 | Endometrial cancer_Homo sapiens_hsa05213 | 0.77458450 |
88 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.76636964 |
89 | Amoebiasis_Homo sapiens_hsa05146 | 0.76168539 |
90 | Cell cycle_Homo sapiens_hsa04110 | 0.75546691 |
91 | Other glycan degradation_Homo sapiens_hsa00511 | 0.75515878 |
92 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.74725724 |
93 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.74381201 |
94 | HTLV-I infection_Homo sapiens_hsa05166 | 0.72703607 |
95 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.72478852 |
96 | Hepatitis C_Homo sapiens_hsa05160 | 0.71598746 |
97 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.70378614 |
98 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.69749084 |
99 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.67743082 |
100 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.67384571 |
101 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.66788565 |
102 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.66574967 |
103 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.66139166 |
104 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.66089573 |
105 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64565917 |
106 | Thyroid cancer_Homo sapiens_hsa05216 | 0.62324026 |
107 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62274228 |
108 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.61696772 |
109 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.61223961 |
110 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60559027 |
111 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59937685 |
112 | Focal adhesion_Homo sapiens_hsa04510 | 0.57043340 |
113 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.56947791 |
114 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.55670397 |
115 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.55479118 |
116 | Insulin resistance_Homo sapiens_hsa04931 | 0.54232161 |
117 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52237584 |
118 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47475952 |
119 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46468185 |
120 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44018405 |
121 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.39235617 |
122 | * Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34635970 |
123 | Prostate cancer_Homo sapiens_hsa05215 | 0.33627241 |